Oaktree Capital Management LP Decreases Stock Position in Infosys Limited (NYSE:INFY)

Oaktree Capital Management LP trimmed its stake in shares of Infosys Limited (NYSE:INFY) by 2.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,677,679 shares of the technology company’s stock after selling 33,833 shares during the quarter. Oaktree Capital Management LP’s holdings in Infosys were worth $36,775,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. BHK Investment Advisors LLC boosted its holdings in Infosys by 2.3% in the fourth quarter. BHK Investment Advisors LLC now owns 22,785 shares of the technology company’s stock valued at $499,000 after acquiring an additional 507 shares in the last quarter. Outlook Wealth Advisors LLC lifted its holdings in Infosys by 2.8% in the fourth quarter. Outlook Wealth Advisors LLC now owns 18,405 shares of the technology company’s stock worth $403,000 after buying an additional 508 shares during the period. GAMMA Investing LLC raised its position in shares of Infosys by 14.2% in the 4th quarter. GAMMA Investing LLC now owns 4,496 shares of the technology company’s stock worth $99,000 after acquiring an additional 560 shares in the last quarter. Flagship Harbor Advisors LLC lifted its stake in shares of Infosys by 6.2% in the 4th quarter. Flagship Harbor Advisors LLC now owns 11,026 shares of the technology company’s stock valued at $242,000 after purchasing an additional 641 shares during the period. Finally, Atomi Financial Group Inc. boosted its position in shares of Infosys by 1.7% during the fourth quarter. Atomi Financial Group Inc. now owns 38,263 shares of the technology company’s stock valued at $839,000 after purchasing an additional 655 shares in the last quarter. 16.20% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have commented on the company. StockNews.com lowered Infosys from a “buy” rating to a “hold” rating in a research report on Thursday, March 20th. Hsbc Global Res raised shares of Infosys from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. Guggenheim restated a “neutral” rating on shares of Infosys in a report on Friday, January 17th. CLSA upgraded shares of Infosys from a “hold” rating to an “outperform” rating in a report on Friday, March 7th. Finally, HSBC upgraded Infosys from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Infosys currently has a consensus rating of “Hold” and a consensus target price of $19.70.

Infosys Stock Performance

INFY opened at $18.17 on Friday. The company’s 50-day simple moving average is $20.45 and its two-hundred day simple moving average is $21.75. The stock has a market capitalization of $75.26 billion, a P/E ratio of 23.00, a P/E/G ratio of 3.50 and a beta of 1.01. Infosys Limited has a 52-week low of $16.04 and a 52-week high of $23.63.

Infosys (NYSE:INFY) last issued its quarterly earnings data on Thursday, January 16th. The technology company reported $0.19 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.19. Infosys had a net margin of 17.28% and a return on equity of 31.60%. During the same quarter in the prior year, the business earned $0.18 EPS. Research analysts forecast that Infosys Limited will post 0.74 EPS for the current fiscal year.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.